ReviewAutoimmune diseases in the intensive care unit. An update☆
Introduction
Systemic manifestations of autoimmune diseases (ADs), which are a heterogeneous group of entities, can become so severe that they endanger the lives of patients. Of all the patients with ADs presenting to the emergency room, the majority have a rheumatologic AD and up to 25% of them require hospitalization. Of these, up to one third will require care and support in an intensive care unit (ICU) [1]. The reported in-ICU mortality of patients with ADs reaches as high as 55% depending on the series [1], [2], [3]. Besides increased risk of mortality, critical illness is also associated with other long-term outcomes such as persistent cognitive impairment [4], which has a negative impact on quality of life and the ability of those who survived an illness that required ICU to reintegrate into daily life [5], [6].
Patients with any of these diseases usually have multiple risk factors for in-hospital mortality and morbidity and are most likely to end up in the ICU, where they represent a challenge for the entire intensive care team. Moreover, it has been reported that, from 1996 to 2003, between 7 and 42% of individuals with an AD were first diagnosed during their ICU stay [7], [8], [9], [10], [11]. This supports our argument that this group of diseases should always be considered in the differential diagnosis in patients at ICU in order to not delay prompt and accurate treatment.
In 2005, we published a case series report and review of literature of patients with ADs requiring intensive care in a third level hospital [2]. Since then, there are no current reports that describe whether the AD situation in the ICU remains the same or if it has changed over time given the advances in the diagnostic procedures that allow an early diagnosis and aggressive treatment of ADs. The aim of the present study was to update the causes of admission, clinical features, and outcomes of patients with ADs requiring intensive care as well as variables associated with mortality that could be possible prognostic mortality factors. Another goal was to describe the state of the art of alternative therapeutic strategies in the ICU to manage life-threatening conditions and manifestations common to all ADs focusing on therapeutic plasma exchange (TPE) and intravenous immunoglobulins (IVIg).
Section snippets
Search strategy
A search was done of PubMed (2005–2011), SCOPUS (2005–2011), SciELO (2005–2011), and LILACS (2005–2011) up to December of 2011 by two reviewers independently to identify studies that measured mortality and described causes of admission, clinical features, variables associated with mortality, alternative therapeutic strategies, and outcomes of patients with ADs. In the search strategy, the combinations of the following MeSH terms were used: “Systemic Vasculitis” [Mesh], “Vasculitis” [Mesh],
Search results and study characteristics
Using our search strategy, 1240 articles were identified and, of these, 123 were chosen for full text review. One hundred and five articles met inclusion criteria and were included in the review (Fig. 1). The articles were grouped as case series reports [2], [3], [7], [9], [10], [11], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36] (Table 1, Table 2), case reports [37], [38], [39], [40], [41], [42], [43],
Discussion
After retrieving all relevant articles, and doing a thorough review of the information, it became evident that there have not been a significant number of publications on the subject in the period of 2005 to 2011. Therefore, we decided to compare the behavior of ADs in the ICU before and after year 2000. This cutoff point in time was selected because of the change in the prevalence of the most frequently reported ADs from RA to SLE, which indicates a change in the dynamics of these disorders in
Conclusions
In the ICU, ADs generate significant mortality according to one of the latest case series which showed an overall in-ICU mortality of up to 55%. Of this group of diseases, SLE, RA and systemic vasculitis are the most common ones associated with admission to the ICU. Although APACHE II score and other variables such as the previous health status have been associated with mortality, studies are needed to develop a prognosis model that would make it possible to combine all variables that might
Take-home messages
- •
The most frequent autoimmune diseases (ADs) found in an intensive care unit (ICU) in the last decade are systemic lupus erythematosus, rheumatoid arthritis and systemic vasculitis.
- •
High APACHE score, multi-organ dysfunction, older age and cytopenia are associated with mortality.
- •
Variables influencing mortality should be promptly identified to improve outcomes.
- •
AD should always be considered in patients with life threatening conditions in ICU.
Acknowledgements
We thank all the members of the Center for Autoimmunity Diseases Research (CREA) for their fruitful discussions. OLQ wishes to thank Juan Carlos Díaz Cortes for his constant support and inspiration. This work was financed by Colciencias (122254531722), and the Universidad del Rosario, Bogota, Colombia.
References (162)
- et al.
Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome
Crit Care Clin
(2002) - et al.
Long-term neurocognitive function after critical illness
Chest
(2006) - et al.
The relationship between cognitive performance and employment and health status in long-term survivors of the acute respiratory distress syndrome: results of an exploratory study
Gen Hosp Psychiatry
(2001) - et al.
Cognitive functioning, mental health, and quality of life in ICU survivors: an overview
Crit Care Clin
(2009) - et al.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
J Clin Epidemiol
(2009) - et al.
Outcome of patients with systemic rheumatic diseases admitted to intensive care units: a retrospective study of 39 cases
Rev Med Interne
(2000) - et al.
Inadequate antimicrobial treatment for nosocomial infection is a mortality risk factor for systemic lupus erythematous patients admitted to intensive care unit
Am J Med Sci
(2010) - et al.
Outcome of patients with small-vessel vasculitis admitted to a medical ICU
Chest
(2007) - et al.
The morbidity and outcome of patients with Guillain–Barre syndrome admitted to the intensive care unit
J Neurol Sci
(2008) - et al.
Fatal disseminated adenovirus infection in a young adult with systemic lupus erythematosus
J Clin Virol
(2011)
The tissue's the issue
Am J Med
Severe coronary artery disease in the setting of Henoch–Schoenlein purpura
Int J Cardiol
Radiotherapy for a pulmonary aspergilloma complicating p-ANCA positive small vessel vasculitis
J Infect
Multi-organ failure as first clinical sign of macrophage activation syndrome in childhood Still's disease
An Pediatr (Barc)
Utility of plasmapheresis in intensive care
Med Intensiva
Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature
Autoimmun Rev
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American college of chest physicians task force
Chest
Serum procalcitonin in systemic autoimmune diseases—where are we now?
Semin Arthritis Rheum
Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature
Lupus
Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit
J Clin Rheumatol
Prognosis of systemic diseases diagnosed in intensive care units
Presse Med
Pulmonary vasculitis in the intensive care unit
J Intensive Care Med
Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients
J Rheumatol
Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit
Intensive Care Med
Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit
Rheumatology (Oxford)
The Oxford 2011 levels of evidence
Predicting outcome from intensive care for patients with rheumatologic diseases
J Rheumatol
Outcome of patients with systemic rheumatic disease admitted to medical intensive care units
Ann Rheum Dis
An audit of patients with rheumatic disease requiring medical intensive care
Ann Acad Med Singapore
Outcome of patients with rheumatic diseases that requires attention in the medical intensive care unit
J Clin Rheumatol
Study of critically ill patients with systemic lupus erythematosus
Crit Care Med
Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome
Ann Rheum Dis
Outcome of patients with systemic lupus erythematosus in intensive care unit
Lupus
Survival of patients with SLE admitted to an intensive care unit—a retrospective study
Clin Rheumatol
Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study
Crit Care
Lupus eritematoso sistémico en la unidad de cuidados intensivos de medicina del Hospital Nacional Cayetano Heredia
Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit
Lupus
Perfil dos pacientes com lúpus eritematoso sistêmico, internados na unidade de terapia intensiva de um hospital universitário de Fortaleza
Revista Brasileira de Terapia Intensiva
Predicting outcome and survival in patients with Wegener's granulomatosis treated on the intensive care unit
Scand J Rheumatol
Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit
Ren Fail
The role of non-invasive ventilation and factors predicting extubation outcome in myasthenic crisis
Neurocrit Care
Critical care of myasthenia gravis in a resource poor setting: a study of South East Nigeria
Neurologist
Life-threatening complications of Crohn's disease and ulcerative colitis: a systematic analysis of admissions to an ICU during 18 years
Dtsch Med Wochenschr
Paediatric intensive care admissions for acute diabetes complications
Diabet Med
Autoimmune fulminant liver failure in adults: experience in a Japanese center
Hepatol Res
Outcome of patients having dermatomyositis admitted to the intensive care unit
Clin Rheumatol
Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis
Clin Rheumatol
Dermatomyositis with catastrophic pulmonary involvement
Lupus
Non invasive mechanical ventilation in intensive care unit in patient with respiratory failure as the first manifestation of dermatomyositis
An Med Interna
Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases
Clin Exp Rheumatol
Cited by (72)
Arboviruses (Alphavirus) related to autoimmune rheumatic diseases: Triggers and possible therapeutic interventions
2023, Translational Autoimmunity: Volume 6: Advances in Autoimmune Rheumatic DiseasesOutcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases
2022, Autoimmunity ReviewsMortality and its risk factors in critically ill patients with connective tissue diseases: A meta-analysis
2022, European Journal of Internal MedicinePrevalence of hospital readmissions and related factors in patients with autoimmune diseases
2021, Journal of Translational AutoimmunityCitation Excerpt :Therefore, this group of diseases is known to cause a significant hospital and even economic burden [4,5]. A meta-analysis (2013) done in Colombia, found that, of all the patients with an AID admitted to the emergency department, up to 25% required hospitalization and, of these, up to one third required care and support in the ICU [6]. In addition, factors related to hospital readmissions are connected to an increase in morbidity and mortality, the cost of the disease, and effect on the patient's quality of life.
Systemic lupus erythematosus and critical illness
2020, AACN Advanced Critical Care
- ☆
The authors do not have any financial relationships with or interests in any commercial companies pertaining to this educational activity.